The brain’s response to disease and injury depends on a complex interaction between inflammation, immune activity, and the health of neuronal connections. In multiple sclerosis, researchers identified the FLAP/LTB4 pathway in microglia as a potential target for reducing harmful inflammation. In chronic traumatic brain injury, SCF and G-CSF shifted gene activity in brain-infiltrating immune cells toward pathways linked to regulation and tissue repair.
A third study found that LRRK2 helps control synaptic activity by regulating the actin structures that shape neuronal connections, offering new insight into early dysfunction in Parkinson’s disease. Together, these findings show how immune signaling and synaptic stability can influence neurological damage and recovery, while revealing new therapeutic directions across several brain disorders.
1. Microglial 5-LOX-activating protein antagonism alleviates leukotriene-driven neuroinflammation
Researchers identified the FLAP/LTB4 pathway in microglia as a key driver of neuroinflammation in multiple sclerosis. Blocking FLAP reduced inflammatory signaling and disease severity in an MS mouse model, highlighting a potential new therapeutic target for limiting chronic CNS inflammation.
2. Hematopoietic Growth Factors Induce More Extensive Transcriptomic Remodeling in Cerebral Monocytes/Macrophages than in Microglia During the Chronic Phase of Traumatic Brain Injury
In mice with chronic traumatic brain injury, treatment with SCF and G-CSF produced strong gene-expression changes in brain-infiltrating monocytes and macrophages, activating pathways associated with immune regulation and tissue repair. The findings may help explain how these growth factors promote recovery long after brain injury.
3. LRRK2 regulates synaptic function through modulation of actin cytoskeletal dynamics
Researchers found that LRRK2 helps regulate BDNF-driven synaptic activity by controlling the actin cytoskeleton that shapes neuronal connections. Disrupting LRRK2 altered synapse maturation and signaling, revealing a potential mechanism behind early synaptic dysfunction in Parkinson’s disease.
If you’d like to stay informed of the latest publications and breakthroughs in neuron regeneration, join our email newsletter to the right (or below on mobile). We send out weekly updates with the latest papers and studies, as well as podcast episodes with the people driving Neuroregenerative breakthroughs.
